- ROUNDTABLE: Pharmacy’s future in sync with technology
- Study: Limiting NPs' scope of practice leads to higher costs
- Pharmagen launches Warfarin-friendly multivitamin
- Walgreens offers free blood-pressure testing in support of American Heart Month
- Lumene unveils product innovation, new packaging for 2014
HYDERABAD, India — Indian drug maker Dr. Reddy's Labs has launched a generic treatment for epilepsy, the company said.
Dr. Reddy's announced the launch of divalproex sodium extended-release tablets in the 250-mg and 500-mg strengths, used to treat epileptic seizures. The 250-mg tablets are available in bottle count sizes of 100, while the 500-mg tablets are available in sizes of 100 and 500.
The drug is a generic version of AbbVie's Depakote ER. Branded and generic versions of the drug had sales of about $194 million during the 12-month period that ended in June, according to IMS Health.
Are you a nurse practitioner or physician's assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.